Overzicht van nieuwe geneesmiddelen (ATC-codes) in 2012 met de vergoeding per jaar
- Raming voor de totale Zvw-populatie
| Introductiejaar | ATC-code | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012 | A10BD11 Metformine met linagliptine | 718 | 19.940 | 38.983 | 53.962 | 60.149 | 63.208 | 73.744 | 83.786 | 94.612 | 101.307 | 106.236 | 111.942 |
| A10BH05 Linagliptine | 526.965 | 1.460.409 | 1.718.649 | 2.051.612 | 2.308.785 | 2.364.303 | 2.479.013 | 2.905.308 | 3.282.860 | 3.248.786 | 3.429.096 | 3.162.015 | |
| B01AF02 Apixaban | 2.654 | 193.280 | 2.035.484 | 7.835.703 | 17.148.379 | 31.311.176 | 46.041.287 | 61.322.576 | 77.029.241 | 93.343.024 | 113.774.992 | 121.620.932 | |
| G03AA14 Estradiol met nomegestrol | 17.566 | 51.689 | 56.968 | 54.584 | 55.027 | 51.818 | 57.746 | 29.757 | 3.647 | 30.096 | 46.803 | 64.109 | |
| J05AG05 Rilpivirine | 76.688 | 148.190 | 280.256 | 277.323 | 254.597 | 289.984 | 313.954 | 295.315 | 270.419 | 392.024 | 1.174.610 | 2.212.566 | |
| J05AR08 Emtricitabine met tenofovir disoproxil en rilpivirine | 2.548.969 | 10.915.363 | 16.177.238 | 15.577.126 | 13.962.095 | 9.621.297 | 7.356.891 | 6.008.340 | 4.924.859 | 2.969.786 | 2.204.603 | 1.965.639 | |
| L04AE01 Immunosuppressiva | 2.973.014 | 9.885.529 | 16.343.466 | 16.699.216 | 17.409.924 | 19.050.389 | 21.880.134 | 23.131.165 | 21.647.746 | 24.124.404 | 23.138.076 | 18.040.609 | |
| N07XX08 Tafamidis | 94.524 | 700.098 | 876.787 | 921.278 | 1.471.426 | 1.999.551 | 2.514.681 | 3.486.909 | 3.879.462 | 3.545.545 | 26.845.195 | 41.491.730 | |
| R03AK11 Formoterol met fluticason | 84.816 | 915.779 | 1.386.189 | 1.868.130 | 2.390.466 | 2.460.153 | 2.402.422 | 2.241.551 | 2.038.626 | 1.872.109 | 1.990.464 | 1.872.428 | |
| Totaal | 6.325.915 | 24.290.277 | 38.914.021 | 45.338.933 | 55.060.846 | 67.211.879 | 83.119.872 | 99.504.707 | 113.171.472 | 129.627.082 | 172.710.074 | 190.541.969 |